Chemistry Reference
In-Depth Information
72. Hecht SM. Bleomycin group antitumor agents. In: Anticancer Agents from Natural
Products. Cragg GM, Kingston DGI, Newman DJ, eds. 2005. Taylor and Francis,
Boca Raton, FL. pp. 357 - 381.
73. Tao Z-F, Konishi K, Keith G, Hecht SM. An efficient mammalian transfer RNA target
for bleomycin. J. Am. Chem. Soc. 2006;128:14806 - 14807.
74. Kumar SG, Lipman R, Cummings J, Tomasz M. Mitomycin c-DNA adducts gener-
ated by dt-diaphorase. Revised mechanism of the enzymatic reductive activation of
mitomycin C. Biochemistry 1997;36:14128 - 14136.
75. Remers WA. The mitomycins. In: Anticancer Agents from Natural Products. Cragg
GM, Kingston DGI, Newman DJ, eds. 2005. Taylor and Francis, Boca Raton, FL.
pp. 475 - 497.
76. Lee MD, Dunne TS, Siegel MM, Chang CC, Morton GO, Borders DB. Calichemicins,
a novel family of antitumor antibiotics. 1. Chemistry and partial structure of cali-
chemicin
J. Am. Chem. Soc. 1987;109:3464 - 3466.
77. Lee MD, Dunne TS, Chang CC, Ellestad GA, Siegel MM, Morton GO, McGahren
WJ, Borders DB. Calichemicins, a novel family of antitumor antibiotics. 2. Chemistry
and structure of calichemicin
γ
J. Am. Chem. Soc. 1987;109:3466 - 3468.
78. Golik J, Clardy J, Dubay G, Groenewold G, Kawaguchi H, Konishi M, Krishnan
B, Ohkuma H, Saitoh K, Doyle TW. Esperamicins, a novel class of potent anti-
tumor antibiotics. 2. Structure of esperamicin X. J. Am. Chem. Soc. 1987;109:
3461 - 3462.
79. Golik J, Dubay G, Groenewold G, Kawaguchi H, Konishi M, Krishnan B, Ohkuma
H, Saitoh K, Doyle TW. Esperamicins, a novel class of potent antitumor antibi-
otics. 3. Structures of esperamicins A1, A2, and A1b. J. Am. Chem. Soc. 1987;109:
3462 - 3464.
80. Hamann PR, Upeslacis J, Borders DB. Enediynes. In: Anticancer Agents from Natural
Products. Cragg GM, Kingston DGI, Newman DJ, eds. 2005. Taylor and Francis, Boca
Raton, FL. pp. 451 - 474.
81. Rinehart KL, Holt TG, Fregeau NL, Stroh JG, Keifer PA, Sun F, Li LH, Martin DG.
Ecteinascidins 729, 743, 745, 759a, 759b, and 770: potent antitumor agents from the
caribbean tunicate
Ecteinascidia turbinata
. J. Org. Chem. 1990;55:4512 - 4515.
82. Wright AE, Forleo DA, Gunawardana GP, Gunasekera SP, Koehn FE, McConnell OJ.
Antitumor tetrahydroisoquinoline alkaloids from the colonial ascidian
Ecteinascidia
turbinata
. J. Org. Chem. 1990;55:4508 - 4512.
83. Cuevas C, Perez M, Martin M, Chicharro JL, Fernandez-Rivas C, Flores M, Francesch
A, Gallefo P, Zarzuelo M, de la Calle F, et al. Synthesis of ecteinascidin ET-743 and
phthalascidin PT-650 from cyanosafracin B. Org. Lett. 2000;2:2545 - 2548.
84. Fayette J, Coquard IR, Alberti L, Ranchere D, Boyle H, Blay J-Y. ET-743: a novel
agent with activity in soft tissue sarcomas. Oncologist 2005;10:827 - 832.
85. Lynch GR, Lane M. Other antitumor antibiotics. In: Cancer Management in Man.
Woolley PV, ed. 1989. Kluwer Academic Publishers, Dordrecht. pp. 134 - 146.
86. Koschmieder S, Agrawal S, Radomska HS, Huettner CS, Tenen DG, Ottmann OG,
Berdel WE, Serve HL, Muller-Tidow C. Decitabine and vitamin D3 differentially
affect hematopoietic transcription factors to induce monocytic differentiation. Int.
Oncol. 2007;30:349 - 355.
87. Dolan ME. Inhibition of DNA repair as a means of increasing the antitumor activity
of DNA reactive agents. Adv. Drug Deliv. Rev. 1997;26:105 - 118.
γ
